AIM ImmunoTech Inc AIM:NYSE American

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:47 PM EDT
0.43UNCH (UNCH)
Volume
3,212
Close
0.43quote price arrow up+0.0045 (+1.0576%)
Volume
157,201
52 week range
0.32 - 0.75
Loading...
  • Open0.43
  • Day High0.46
  • Day Low0.4251
  • Prev Close0.4255
  • 52 Week High0.75
  • 52 Week High Date07/21/23
  • 52 Week Low0.32
  • 52 Week Low Date03/14/24

Key Stats

  • Market Cap21.458M
  • Shares Out49.90M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta-0.12
  • YTD % Change-2.25

KEY STATS

  • Open0.43
  • Day High0.46
  • Day Low0.4251
  • Prev Close0.4255
  • 52 Week High0.75
  • 52 Week High Date07/21/23
  • 52 Week Low0.32
  • 52 Week Low Date03/14/24
  • Market Cap21.458M
  • Shares Out49.90M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta-0.12
  • YTD % Change-2.25

RATIOS/PROFITABILITY

  • EPS (TTM)-0.60
  • P/E (TTM)-0.72
  • Fwd P/E (NTM)-0.88
  • EBITDA (TTM)-31.665M
  • ROE (TTM)-122.42%
  • Revenue (TTM)202,000.007
  • Gross Margin (TTM)79.21%
  • Net Margin (TTM)-14,337.62%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On AIM ImmunoTech Inc

 

Profile

MORE
AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular ribonucleic acid (RNA) molecules, and Alferon N Injection (Interferon alfa). Its lead product is an investigational drug called Ampligen (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator...
William Mitchell M.D., Ph.D.
Independent Chairman of the Board
Thomas Equels Esq., J.D.
President, Chief Executive Officer, Executive Vice Chairman
Peter Rodino III
Chief Operating Officer, Executive Director - Governmental Relations, General Counsel, Secretary
Robert Dickey IV
Chief Financial Officer
Address
2117 SW Highway 484
Ocala, FL
34473-7949
United States

Top Peers

SYMBOLLASTCHG%CHG
ITRM
Iterum Therapeutics PLC
1.55-0.03-1.90%
ADXS
Ayala Pharmaceuticals Inc
0.54UNCHUNCH
LSTA
Lisata Therapeutics Inc
2.77+0.12+4.53%
SNSE
Sensei Biotherapeutics Inc
0.9917-0.006-0.6014%
ENLV
Enlivex Therapeutics Ltd
1.50+0.18+13.64%